Equideum Health has partnered with Nokia Bell Labs to research cognitive augmentation using blockchain combined with AI and edge devices such as earpieces, smartwatches, and home devices.
The joint applied research agenda would be on how they would approach the ethics, identity, cybersecurity, and compliance challenges concerning edge data on all devices, including earables and other remote telemetry devices currently being used, according to Heather Flannery, CEO of Equideum Health.
Nokia has created an earable — a wearable ear gadget with a microphone and speaker – that can utilize on-device machine learning to assist individuals in understanding and responding to the environment around them.
This type of device receives a wide range of very private data, which raises several ethical concerns.
Flannery noted that the concern is whether a guardian or legal representative might opt-in to share data that the patient would not agree to if they were capable of making the decision themself. That’s especially where financial incentives are involved.
She added that they bring improvements in transparency, audio, privacy, and cybersecurity. Improvements over baseline versus further infringement or compromise on the agency and empowerment of the individual.
There have been numerous reports in the media of people in care being mistreated or ignored. Most care facilities contain sensors and monitors, which are also IoT devices,
in addition to wearables. The Equideum Foundation's director, Dr. Pierre Vigilance, pointed out that better data management could assist individuals to get better care.


Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



